Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.

Derosa G, Franzetti I, Querci F, D'Angelo A, Maffioli P.

Pharmacotherapy. 2015 Nov;35(11):983-90. doi: 10.1002/phar.1648. Epub 2015 Nov 2.

PMID:
26598090
2.

Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial.

Derosa G, Mugellini A, Querci F, Franzetti I, Pesce RM, D'Angelo A, Maffioli P.

Sci Rep. 2015 Aug 5;5:12603. doi: 10.1038/srep12603.

3.

Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.

Derosa G, Querci F, Franzetti I, Dario Ragonesi P, D'Angelo A, Maffioli P.

Hypertens Res. 2015 Oct;38(10):690-4. doi: 10.1038/hr.2015.57. Epub 2015 May 21.

PMID:
25994603
4.

Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.

Derosa G, Franzetti I, Querci F, Romano D, D'Angelo A, Maffioli P.

Diabetes Obes Metab. 2015 Jun;17(6):554-9. doi: 10.1111/dom.12454. Epub 2015 Apr 2.

PMID:
25694300
5.

Continuous subcutaneous insulin infusion in Italy: third national survey.

Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A, Grassi G, Iafusco D, Rabbone I, Schiaffini R; Italian Study Group on Diffusion of CSII.

Diabetes Technol Ther. 2015 Feb;17(2):96-104. doi: 10.1089/dia.2014.0242. Epub 2014 Dec 5.

PMID:
25479035
6.

High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).

Zampetti S, Campagna G, Tiberti C, Songini M, Arpi ML, De Simone G, Cossu E, Cocco L, Osborn J, Bosi E, Giorgino F, Spoletini M, Buzzetti R; NIRAD Study Group.

Eur J Endocrinol. 2014 Dec;171(6):697-704. doi: 10.1530/EJE-14-0342. Epub 2014 Sep 11.

7.

Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy.

Derosa G, Cicero AF, Franzetti IG, Querci F, Carbone A, Ciccarelli L, D'Angelo A, Fogari E, Maffioli P.

Can J Physiol Pharmacol. 2013 Sep;91(9):724-32. doi: 10.1139/cjpp-2012-0300. Epub 2013 Apr 23.

PMID:
23984793
8.

Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.

Derosa G, Franzetti IG, Querci F, Carbone A, Ciccarelli L, Piccinni MN, Fogari E, Maffioli P.

Pharmacotherapy. 2013 Aug;33(8):817-26. doi: 10.1002/phar.1301. Epub 2013 Jun 6.

PMID:
23744726
9.

A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study.

Derosa G, Cicero AF, Franzetti IG, Querci F, Carbone A, Piccinni MN, D'Angelo A, Fogari E, Maffioli P.

Diabetes Technol Ther. 2013 Mar;15(3):214-22. doi: 10.1089/dia.2012.0272. Epub 2013 Feb 21.

PMID:
23427864
10.

A comparison between sitagliptin or glibenclamide in addition to metformin + pioglitazone on glycaemic control and β-cell function: the triple oral therapy.

Derosa G, Cicero AF, Franzetti IG, Querci F, Carbone A, Piccinni MN, D'Angelo A, Fogari E, Maffioli P.

Diabet Med. 2013 Jul;30(7):846-54. doi: 10.1111/dme.12158. Epub 2013 Mar 29.

PMID:
23413771
11.

Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients.

Derosa G, Carbone A, Franzetti I, Querci F, Fogari E, Bianchi L, Bonaventura A, Romano D, Cicero AF, Maffioli P.

Diabetes Res Clin Pract. 2012 Oct;98(1):51-60. doi: 10.1016/j.diabres.2012.05.022. Epub 2012 Jun 9.

PMID:
22682949
12.

Quality of Life, Wishes, and Needs in Women with Gestational Diabetes: Italian DAWN Pregnancy Study.

Lapolla A, Di Cianni G, Di Benedetto A, Franzetti I, Napoli A, Sciacca L, Torlone E, Tonutti L, Vitacolonna E, Mannino D.

Int J Endocrinol. 2012;2012:784726. doi: 10.1155/2012/784726. Epub 2012 Apr 26.

13.

Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.

Derosa G, Franzetti IG, Querci F, Carbone A, Ciccarelli L, Piccinni MN, Fogari E, Maffioli P.

Diabet Med. 2012 Dec;29(12):1515-23. doi: 10.1111/j.1464-5491.2012.03699.x.

PMID:
22540883
14.

Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients.

Derosa G, Putignano P, Bossi AC, Bonaventura A, Querci F, Franzetti IG, Guazzini B, Testori G, Fogari E, Maffioli P.

Eur J Pharmacol. 2011 Sep;666(1-3):251-6. doi: 10.1016/j.ejphar.2011.05.051. Epub 2011 Jun 1.

PMID:
21645507
15.

Quality of life in pregnancy and post-partum: a study in diabetic patients.

Dalfrà MG, Nicolucci A, Bisson T, Bonsembiante B, Lapolla A; QLISG (Quality of Life Italian Study Group).

Qual Life Res. 2012 Mar;21(2):291-8. doi: 10.1007/s11136-011-9940-5. Epub 2011 Jun 2.

PMID:
21633879
16.

Prepregnancy BMI influences maternal and fetal outcomes in women with isolated gestational hyperglycaemia: a multicentre study.

Lapolla A, Bonomo M, Dalfrà MG, Parretti E, Mannino D, Mello G, Di Cianni G; GISOGD.

Diabetes Metab. 2010 Sep;36(4):265-70. doi: 10.1016/j.diabet.2010.01.008. Epub 2010 Jul 2.

17.

Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.

Derosa G, Maffioli P, Ferrari I, Mereu R, Ragonesi PD, Querci F, Franzetti IG, Gadaleta G, Ciccarelli L, Piccinni MN, D'Angelo A, Salvadeo SA.

Horm Metab Res. 2010 Aug;42(9):663-9. doi: 10.1055/s-0030-1255036. Epub 2010 Jun 17.

PMID:
20560108
18.

Exenatide versus glibenclamide in patients with diabetes.

Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Ragonesi PD, Querci F, Franzetti IG, Gadaleta G, Ciccarelli L, Piccinni MN, D'Angelo A, Cicero AF.

Diabetes Technol Ther. 2010 Mar;12(3):233-40. doi: 10.1089/dia.2009.0141.

PMID:
20151774
19.

Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.

Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Ragonesi PD, Querci F, Franzetti IG, Gadaleta G, Ciccarelli L, Piccinni MN, D'Angelo A, Cicero AF.

Metabolism. 2010 Jun;59(6):887-95. doi: 10.1016/j.metabol.2009.10.007. Epub 2009 Dec 16.

PMID:
20015525
20.

Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.

Derosa G, D'Angelo A, Franzetti IG, Ragonesi PD, Gadaleta G, Scalise F, Ciccarelli L, Piccinni MN, Cicero AF.

J Clin Pharm Ther. 2009 Jun;34(3):267-76.

PMID:
19650249
Items per page

Supplemental Content

Loading ...
Write to the Help Desk